Jointly-Owned Program Patents. Unless the Parties agree otherwise, Isis and Biogen Idec will share equally the Patent Costs associated with the Prosecution and Maintenance of Jointly-Owned Program Patents; provided that, either Party may decline to pay its share of costs for filing, prosecuting and maintaining any Jointly-Owned Program Patents in a particular country or particular countries, in which case the declining Party will, and will cause its Affiliates to, assign to the other Party (or, if such assignment is not possible, grant a fully-paid exclusive license in) all of their rights, titles and interests in and to such Jointly-Owned Program Patents.
Appears in 4 contracts
Samples: License Agreement (Isis Pharmaceuticals Inc), License Agreement (Isis Pharmaceuticals Inc), Option and License Agreement (Isis Pharmaceuticals Inc)
Jointly-Owned Program Patents. Unless the Parties agree otherwise, Isis Ionis and Biogen Idec will share equally the Patent Costs associated with the Prosecution and Maintenance of Jointly-Owned Program Patents; provided that, that either Party may decline to pay its share of costs for filing, prosecuting and maintaining any Jointly-Owned Program Patents in a particular country or particular countries, in which case the declining Party will, and will cause its Affiliates to, assign to the other Party (or, if such assignment is not possible, grant a fully-paid exclusive license in) all of their rights, titles and interests in and to such Jointly-Owned Program Patents.
Appears in 3 contracts
Samples: Option and License Agreement (Ionis Pharmaceuticals Inc), Option and License Agreement (Ionis Pharmaceuticals Inc), Option and License Agreement (Ionis Pharmaceuticals Inc)
Jointly-Owned Program Patents. Unless the Parties agree otherwise, Isis and Biogen Idec Bayer will share equally the Patent Costs associated with the Prosecution and Maintenance of Jointly-Owned Program Patents; provided that, either Party may decline to pay its share of costs for filing, prosecuting and maintaining any Jointly-Owned Program Patents in a particular country or particular countries, in which case the declining Party will, and will cause its Affiliates to, assign to the other Party (or, if such assignment is not possible, grant a fully-paid exclusive license in) all of their rights, titles and interests in and to such Jointly-Owned Program Patents.
Appears in 2 contracts
Samples: Confidential License Agreement, License Agreement (Isis Pharmaceuticals Inc)
Jointly-Owned Program Patents. Unless the Parties agree otherwise, Isis Ionis and Biogen Idec will share equally the Patent Costs associated with the Prosecution and Maintenance of Jointly-Owned Program Patents; provided that, that either Party may decline to pay its share of costs for filing, prosecuting and maintaining any Jointly-Owned Program Patents in a particular country or particular countries, in which case the declining Party will, and will cause its Affiliates to, assign to the other Party (or, if such assignment is not possible, grant a fully-paid exclusive license in) all of their rights, titles and interests interest in and to such Jointly-Owned Program Patents.
Appears in 1 contract
Samples: Option and License Agreement (Ionis Pharmaceuticals Inc)
Jointly-Owned Program Patents. Unless the Parties agree otherwise, Isis Ionis and Biogen Idec will share equally the Patent Costs associated with the Prosecution and Maintenance of Jointly-Owned Program Patents; provided that, that either Party may decline to pay its share of costs for filing, prosecuting and maintaining any Jointly-Owned Program Patents in a particular country or particular countries, in which case the declining Party will, and will cause its Affiliates to, assign to the other Party (or, if such assignment is not possible, grant a fully-paid exclusive license in) all of their rights, titles title and interests in and to such Jointly-Owned Program Patents.
Appears in 1 contract
